BioNTech proceeding with COVID-19 shot in line with WHO guidance
Germany's BioNTech said it was on track to introduce a COVID-19 shot by the early fall in the Northern Hemisphere that is adapted to currently dominant virus variants in line with recommendations by the World Health Organization.
BioNTech was targeting regulatory approval by the end of the summer to allow for a seasonal vaccination campaign to start in early autumn, CEO and co-founder Ugur Sahin told shareholders at the biotech firm's annual general meeting on Thursday.
BioNTech is collaborating on the vaccine with Pfizer in markets outside of greater China.
A WHO advisory group last week recommended that this year's COVID-19 booster shots be updated to target one of the currently dominant XBB variants.
BioNTech/PFizer's new formulation would aim to produce antibody responses to the XBB.1.5 or XBB.1.16 variants, as preferred by the WHO, Sahin said, adding that the partners would introduce a ready-to-use single dose, a change from the multi-dose vials that were standard during the pandemic.
Moderna and Novavax have also been working on versions of their respective vaccines targeting XBB.1.5 and other currently circulating strains.
CTVNews.ca Top Stories

Homeowners brace for mortgage payment shock amid higher-for-longer rate outlook
From ultra-low interest rates that led to a huge spike in real estate demand to the speed with which interest rates shot up to levels not seen in a generation, it's been hard to keep up with the shifting landscape for mortgage holders.
McDonald's, Wendy's defeat lawsuit over size of burgers
McDonald's and Wendy's have defeated a lawsuit accusing them of deceiving hungry diners by exaggerating the size of their burgers.
New study shows where you fall on new internet addiction spectrum
Researchers have come up with categories for people who are addicted to the internet and for those who are at risk.
Trump seethes through the start of trial in New York lawsuit accusing him of lying about his wealth
Aggrieved and defiant, former U.S. president Donald Trump sat through hours of sometimes testy opening statements Monday in a fraud lawsuit that could cost him control of Trump Tower and other prized properties.
Diwali fireworks advisory issued despite warnings it might be discriminatory: emails
An Environment Canada advisory that singled out Diwali fireworks as a reason to prepare for poor air quality last October was issued despite multiple warnings from some staff about it being discriminatory.
Late-night shows return after writers strike as actors resume talks that could end their standoff
Late-night talk shows are returning Monday after a five-month absence brought on by the Hollywood writers strike, while actors completed the first day of talks that could end their own long work walk-off.
Federal ministers still lack mandate letters, two months after majority shuffled
Prime Minister Justin Trudeau has yet to issue mandate letters for his cabinet ministers, two months after announcing an overhaul to his front bench.
Grizzly bear attacks rare, but a risk in wilderness, experts say after Banff deaths
Grizzly bear experts say fatal attacks are extremely rare, but it's always a risk when people venture into the wilderness.
Arajet latest entrant to Canada's crowded budget airline market
Arajet, a discount airline based in the Dominican Republic, says it will launch flights between that country and Toronto and Montreal this fall.